SILVERARC CAPITAL MANAGEMENT, LLC
Position in ORIC — Oric Pharmaceuticals, Inc.
CIK 1816307
BOSTON, MA
Position in ORIC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,001,994
-$5,935,132 QoQ
Shares Held
738,873
-32.8% QoQ
Ownership
0.713%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#42
of 179 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. ORIC ranks #32 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in ORIC
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,001,994 | 738,873 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $13,937,126 | 1,100,010 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,133,820 | 1,116,604 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $23,385,696 | 1,948,808 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,278,414 | 1,800,829 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,496,139 | 2,060,240 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,508,881 | 1,178,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,269,772 | 1,099,490 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,605,990 | 1,075,812 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,303,846 | 1,113,007 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,764,000 | 1,170,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,796,237 | 1,123,345 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,258,378 | 1,450,822 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,184,886 | 1,435,945 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,281,783 | 1,236,296 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,868,774 | 1,208,992 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $4,848,721 | 1,082,304 | Shares | Sole | 2022-07-25 | |
| No filing history on record for this holder in this stock. | ||||||